These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 12639980

  • 21. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.
    Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ.
    EMBO J; 2001 Sep 17; 20(18):5197-206. PubMed ID: 11566883
    [Abstract] [Full Text] [Related]

  • 22. The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.
    Kim W, Kaelin WG.
    Curr Opin Genet Dev; 2003 Feb 17; 13(1):55-60. PubMed ID: 12573436
    [Abstract] [Full Text] [Related]

  • 23. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.
    Yu F, White SB, Zhao Q, Lee FS.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9630-5. PubMed ID: 11504942
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The von Hippel-Lindau tumor suppressor gene.
    Kondo K, Kaelin WG.
    Exp Cell Res; 2001 Mar 10; 264(1):117-25. PubMed ID: 11237528
    [Abstract] [Full Text] [Related]

  • 27. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor.
    Bruick RK.
    Genes Dev; 2003 Nov 01; 17(21):2614-23. PubMed ID: 14597660
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK, Hickey MM, Bezman NA, Chmielecki CA, Carraway NC, Simon MC.
    Cancer Res; 2004 Dec 01; 64(23):8595-603. PubMed ID: 15574766
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway.
    Ratcliffe PJ.
    Blood Purif; 2002 Dec 01; 20(5):445-50. PubMed ID: 12207089
    [Abstract] [Full Text] [Related]

  • 34. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.
    Kaelin WG.
    Biochem Biophys Res Commun; 2005 Dec 09; 338(1):627-38. PubMed ID: 16153592
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes.
    Biju MP, Neumann AK, Bensinger SJ, Johnson RS, Turka LA, Haase VH.
    Mol Cell Biol; 2004 Oct 09; 24(20):9038-47. PubMed ID: 15456877
    [Abstract] [Full Text] [Related]

  • 37. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
    Maynard MA, Ohh M.
    Am J Nephrol; 2004 Oct 09; 24(1):1-13. PubMed ID: 14654728
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
    Yu F, White SB, Zhao Q, Lee FS.
    Cancer Res; 2001 May 15; 61(10):4136-42. PubMed ID: 11358837
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.